One sentence summary: In the yeast Saccharomyces cerevisiae, overexpression of PDR16, or PDR17, a paralog of PDR16, confers resistance to inositol phosphorylceramide synthase inhibitor aureobasidin A, which is widely used as an antifungal drug.
INTRODUCTION
Sphingolipids, one of the components of the eukaryotic biomembrane, are essential for cell growth of yeast Saccharomyces cerevisiae, and thus the inhibition of sphingolipid biosynthesis causes defects of various cellular functions and consequently a severe growth defect (Dickson, Sumanasekera and Lester 2006) . The initial step of biosynthesis of sphingolipids is the condensation of serine and palmitoyl-CoA generating long-chain bases that are reduced and hydroxylated, and then the long-chain bases are converted to ceramides (Cers) via Nacylation (Dickson, Sumanasekera and Lester 2006) (Fig. S1 in the online supplementary material). Complex sphingolipids are formed through the addition of hydrophilic head groups to Cers (Fig. S1 ). In yeast, the simplest complex sphingolipid is inositol phosphorylceramide (IPC), and Aur1 catalyzes the transfer of the phosphoinositol of phosphatidylinositol (PI) to Cers and thereby synthesizes IPCs (Dickson, Sumanasekera and Lester 2006) . Aur1 is essential for yeast cell growth (Nagiec et al. 1997) .
Aureobasidin A (AbA), a cyclic depsipeptide produced by Aureobasidium pullulans R106, inhibits Aur1 activity (Takesako et al. 1993; Heidler and Radding 1995; Nagiec et al. 1997) (Fig. S1 ). AbA exerts high toxicity toward fungi through inhibition of the biosynthesis of IPCs, and is widely used as an antifungal drug against eukaryotic microorganisms having IPCs as complex sphingolipids (Takesako et al. 1993; Zhong, Jeffries and Georgopapadakou 2000) . In S. cerevisiae, AbA treatment results not only in reductions in all the complex sphingolipid levels but also in the accumulation of Cers, both of which are believed to lead to the growth defect caused by this inhibitor (Nagiec et al. 1997) . Several mutations that confer resistance to AbA have been reported (Heidler and Radding 1995; Hashida-Okado et al. 1996) . For example, point mutations of AUR1, which cause substitution of Leu-137, His-157 or Phe-158 by Phe, Tyr or Tyr, respectively, have been identified as dominant mutations that confer AbA resistance (Heidler and Radding 1995; Hashida-Okado et al. 1996) . The enzyme activity of the mutated Aur1 is not inhibited by AbA. In combination with AbA, a mutant of AUR1 named AUR1-C is used as a dominant selection marker to transform various prototrophic industrial yeast cells (Hashida-Okado et al. 1998) . On the other hand, deletion of several sphingolipid-metabolizing enzymes also causes AbA resistance. Although the chain length of fatty acids in Cers is primarily C26 in S. cerevisiae, deletion of ELO3, the gene essential for the biosynthesis of C26 fatty acids, results in biosynthesis of Cers containing C24 or shorter fatty acids (Oh et al. 1997) . The deletion of ELO3 confers resistance to AbA, implying that the chain length of fatty acids in Cer is a critical factor for the AbA-induced cell growth defect (Tani and Kuge 2010b) . Furthermore, when endogenous Cer synthases are replaced by an enzyme from cotton, which results in production of C18-Cers instead of C26-Cers, S. cerevisiae exhibits AbA resistance (Epstein et al. 2012) . In addition, decreased biosynthesis of Cer due to the deletion of Cer synthase genes suppresses the toxicity of AbA (Schorling et al. 2001) .
In this study, we identified PDR16 and PDR17 as novel multicopy suppressors that confer resistance to AbA in S. cerevisiae. The suppressive effect of the overexpression of PDR16 or PDR17 on the growth defect was not observed when expression of the AUR1 gene was repressed by a tetracycline-regulatable system, suggesting that the overexpression of PDR16 reduces the effectiveness of AbA against intracellular Aur1 activity.
MATERIALS AND METHODS

Yeast strains and media
The S. cerevisiae strains used are listed in Table S1 in the online supplementary material. Disruption of PDR16, PDR17 and LEM3 was performed by replacing their open reading frames with the kanMX4 marker from a genome from a yeast knockout library or the pFA6a-kanMX4 vector, or the hphNT1 marker from the pFA6a-hphNT1 vector (Janke et al. 2004) . Occasionally, kanMX4 was replaced with the hygromycin B-resistant gene (from the pFA6a-hphNTI vector (Janke et al. 2004) ) to create hphMX4. For overexpression of PDR16 and PDR17 by a strong and constitutive TEF promoter, a TEF promoter cassette with the natNT2 marker from pYM-N19 was introduced immediately upstream of the initiator ATG of the chromosomal gene, as described previously (Janke et al. 2004) . For tagging of the C-terminus of PDR16 or PDR17 with six copies of the hemagglutinin (HA) epitope (6xHA), a 6xHA fusion cassette containing the hphNT1 marker from the pYM16 vector was introduced immediately upstream of the stop codon of chromosomal PDR16 or PDR17 as described previously (Janke et al. 2004) . The cells were cultured in YPD medium (1% yeast extract, 2% peptone and 2% glucose), SC (synthetic complete) medium (0.67% yeast nitrogen base without amino acids (BD Difco, Heidelberg, Germany) and 2% glucose) containing nutritional supplements, or SC/MSG medium (0.17% yeast nitrogen base without amino acids and ammonium sulphate (BD Difco), 0.1% l-glutamic acid sodium salt hydrate (MSG; Sigma), and 2% glucose) containing nutritional supplements.
Multicopy suppressor screening
A S. cerevisiae genomic DNA library based on YEp13, a multicopy vector with the LEU2 marker (kindly provided by Dr Akihiko Nakano, RIKEN, Japan), was introduced into wild-type cells. After the transformation, cells were cultured in SC/MSG medium lacking leucine at 30
• C for 5 h. Then, the cells were plated on SC/MSG plates lacking leucine but containing 0.3 μg ml −1 AbA, and then incubated at 30 • C for 3 days. Colonies were re-streaked onto SC/MSG plates lacking leucine but containing 0.3 μg ml −1
AbA, and the growth was confirmed. Plasmid DNA from positive clones was isolated and amplified in Escherichia coli, and the DNA sequences were verified with an ABI PRISM R 3100 genetic analyzer (Applied Biosystems, Foster City, CA, USA).
Plasmid
The construction of plasmids used in this study is described in the online supplementary material. The sequences of the oligonucleotide primers used for the construction are listed in Table S2 in the online supplementary material.
Lipid extraction and thin-layer chromatography analysis
Lipids were extracted from S. cerevisiae as described previously (Hanson and Lester 1980) at 10 000 g for 1 min and then extracted once more in the same manner. The resulting supernatants were dried and subjected to mild alkaline treatment using monomethylamine. For this purpose, the lipid extracts were dissolved in 130 μl monomethylamine (40% methanol solution)/water (10:3, v/v), incubated for 1 h at 53
• C, and then dried. The lipids were suspended in 50 μl of chloroform/methanol/water (5:4:1, v/v) and then separated on Silica Gel 60 thin-layer chromatography (TLC) plates (Merck, Whitehouse Station, NJ, USA) with chloroform/methanol/4.2 M ammonia (9:7:2, v/v). The TLC plates were sprayed with 10% copper sulphate in 8% orthophosphoric acid and then heated at 180 • C to visualize lipids. Identification of each complex sphingolipid was performed as described in previous papers (Uemura et al. 2014; Tani and Toume 2015) .
Yeast protein extraction, SDS-PAGE and western blotting
Protein extraction, SDS-PAGE and western blotting were performed as described previously (Tani and Kuge 2010a) . Anti-HA (Sigma) and anti-Pgk1p (Molecular Probes, Carlsbad, CA, USA) were used as primary antibodies. Horseradish peroxidaseconjugated anti-mouse IgG (Molecular Probes) was used as the secondary antibody.
RESULTS
Overexpression of PDR16 or PDR17 confers resistance to AbA
To identify genes related to the growth defect caused by AbA, we screened for multicopy suppressor genes that suppress the growth defect caused by treatment with AbA. A pool of cells was transformed with a yeast genomic library in a high-copy number vector, YEp13, followed by screening for cells exhibiting growth in the presence of AbA. Eighteen colonies were isolated from ∼70 000 transformants. Plasmids extracted from the isolated clones were re-transformed into wild-type cells, and the resistance to AbA treatment was confirmed. Among them, 13 plasmids conferred the resistance to AbA. These plasmids commonly contained one candidate gene, PDR16, which encodes a protein belonging to the phosphatidylinositol transfer protein (PITP) family (Li et al. 2000) . A DNA fragment containing PDR16 and its potential promoter and terminator regions was subcloned into a 2 μ-based vector, pRS425, and the resulting plasmid (pRS425-PDR16) was introduced into wild-type cells. As shown in Fig. 1A , cells harboring pRS425-PDR16 exhibited resistance to AbA. Pdr17, which also belongs to the PITP family, exhibits close sequence similarity to Pdr16 as compared with the other members of the PITP family, and serves a redundant function with Pdr16 (van den Hazel et al. 1999) . Thus, we also examined the effect of overexpression of PDR17. As expected, cells harboring a multicopy vector containing PDR17 also exhibited resistance to AbA (Fig. 1A) . The resistance to AbA was also observed when chromosomal PDR16 or PDR17 was overexpressed under the control of a constitutive and strong TEF promoter (Fig. 1B) . The overexpression of Pdr16 and Pdr17 due to the TEF promoter was confirmed by tagging with 6xHA at the C-terminus of Pdr16 and Pdr17 (Fig. 1C) . In contrast, deletion of PDR17 resulted in an increase in the sensitivity to AbA (Fig. 1D ). Although deletion of PDR16 alone had no effect on the sensitivity to AbA, the sensitivity of pdr16 pdr17 cells was greater than that of pdr17 cells, suggesting that Pdr16 and Pdr17 are coordinately involved in the determination of the sensitivity to AbA (Fig. 1D ).
To investigate whether or not the overexpression of PDR16 from pathogenic fungi, Candida albicans, C. albicans PDR16 was overexpressed in S. cerevisiae under the control of the TEF promoter (pRS415TEFp-CaPDR16). As shown in Fig. 1E , the expression of Candida PDR16 also conferred the resistance to AbA, as well as that of Saccharomyces PDR16, suggesting that the ability of Pdr16 to confer the resistance is conserved in C. albicans.
Effects of overexpression of PITP family proteins on AbA sensitivity
PITP family proteins include Sec14, Sfh1, Csr1 (Sfh2), Pdr16 (Sfh3), Pdr17 (Sfh4) and Sfh5 (Li et al. 2000) . To investigate whether or not overexpression of PITP family proteins other than Pdr16 and Pdr17 confers resistance to AbA, a DNA fragment containing SEC14, SFH1, CSR1 or SFH5, and its potential promoter and terminator regions was subcloned into the pRS425 vector, and then introduced into wild-type cells. As shown in Fig. 2 , strong resistance to AbA was observed only when PDR16 or PDR17 was overexpressed. Cells harboring multicopy plasmids containing SEC14, SFH1 or CSR1 appear to exhibit only weak resistance to AbA as compared with cells harboring the empty vector (Fig. 2) . However, the possibility should be considered that these proteins are not overexpressed at a sufficient level to induce the resistance to AbA.
PI-binding activity of Pdr16 is essential for acquiring resistance to AbA
It has been reported that Pdr16 stimulates the transfer of PI between liposomes (Li et al. 2000) . Two amino acids, Glu-235 and Lys-267, in Pdr16 are conserved among PITP family proteins and essential for the PI-binding activity of Pdr16 (Holic et al. 2014 ). To investigate whether or not the PI-binding activity of Pdr16 is required for the AbA resistance, PDR16-E235A, K267A, a mutant defective in PI binding (Holic et al. 2014) , was overexpressed in yeast cells. As shown in Fig. 3A , PDR16-E235A, K267A-overexpressing cells did not exhibit AbA resistance. It was confirmed that the expression level of Pdr16-E235A, K267A was comparable with that of Pdr16 when both proteins were tagged with 6xHA at their C-termini (Fig. 3B) . The inability of Pdr16-E235A, K267A to confer the resistance to AbA was also observed when the mutant was overexpressed in pdr16 pdr17 cells (Fig. 3A) . These results indicated that the PI-binding activity of Pdr16 is necessary for the acquirement of resistance to AbA.
Overexpression of PDR16 or PDR17 does not confer resistance to the growth defect caused by repression of the AUR1 gene under the tetracycline-regulatable promoter Similar to inhibition of the Aur1 activity on the addition of AbA, repression of expression of the AUR1 gene also causes a severe cell growth defect due to a defect in IPC biosynthesis Kuge 2010b, 2012; Voynova et al. 2015) . Previously, we established a mutant strain that carries the chromosomal AUR1 gene under the control of a tetracycline (Tet)-regulatable promoter (tet-AUR1) (Tani and Kuge 2010b) . This mutant strain exhibits a growth defect in the presence of doxycycline (Dox), which represses expression of the gene under the Tet promoter. Figure 4A shows the effects of Dox on the cell growth of tet-AUR1, tet-AUR1 TEFp-PDR16 and tet-AUR1 TEFp-PDR17 cells. In contrast to the results of AbA treatment, the overexpression of PDR16 or PDR17 did not confer the resistance to AUR1 repression with the Dox treatment. The ineffectiveness of overexpression of PDR16 against the AUR1 repression was also confirmed when the pRS425-PDR16 plasmid was transformed into tet-AUR1 cells (data not shown). We next investigated whether or not the overexpression of PDR16 affects the alteration of complex sphingolipid levels caused by the AbA treatment or the repression of AUR1 expression by the Tet promoter. Figure 4B and C shows the time courses of growth of cells in the presence of AbA or Dox. The growth of wild-type cells began to slow down at 3-6 h after the addition of 0.1 μg ml −1 AbA (Fig. 4B) . In tet-AUR1 cells, the delay of growth was observed at 6-9 h after the addition of 10 μg ml −1 Dox (Fig. 4C) . Thus, we decided to measure the complex sphingolipid levels at 3 or 5 h after the addition of AbA (wild-type and TEFp-PDR16 cells) (Fig. 4D ) and at 5.5 or 8 h after the addition of Dox (tet-AUR1 and tet-AUR1 TEFp-PDR16 cells) (Fig.  4E ). Lipids were extracted from cells, and complex sphingolipids were stained with a copper sulphate and orthophosphoric acid reagent ( Fig. 4D and E) (Toume and Tani 2014) . As reported previously, AbA-treated wild-type cells exhibited reductions in complex sphingolipid levels (Fig. 4D) . The reductions in complex sphingolipid levels were significantly suppressed by the overexpression of PDR16 (AbA-treated wild-type cells versus AbAtreated TEFp-PDR16 cells) (Fig. 4D) . In contrast, significant differences in the reductions in complex sphingolipid levels were not observed between Dox-treated tet-AUR1 and Dox-treated tet-AUR1 TEFp-PDR16 cells (Fig. 4E) . Thus, it was indicated that the AbA sensitivity of cells overexpressing PDR16 or PDR17 with the TEF promoter. Cells were cultured overnight in YPD medium and then spotted onto YPD plates with or without the indicated concentrations of AbA, in 10-fold serial dilutions starting with a density of 0.7 A600 units ml −1 . (C) Western blotting analysis of overexpressed Pdr16-6xHA and Pdr17-6xHA due to the TEF promoter. Cells expressing Pdr16-6xHA or Pdr17-6xHA with the native promoter or TEF promoter were cultured overnight in YPD medium, diluted (0.2 A600 units ml −1 ) in fresh YPD medium, and then incubated for 5 h at 30
• C. Yeast cell extracts were immunoblotted using anti-HA or anti-Pgk1. The details are given in Materials and methods. (D) Effects of deletion of PDR16 and/or PDR17 on AbA sensitivity. (E) Wild-type cells harboring pRS415TEFp-Candida albicans PDR16 (CaPDR16), pRS415TEFp-Saccharomyces cerevisiae PDR16 (ScPDR16), or the empty plasmid were cultured overnight in SC medium lacking leucine, and then spotted onto SC plates lacking leucine with or without the indicated concentrations of AbA, in 10-fold serial dilutions starting with a density of 0.7 A600 units ml −1 . Figure 2 . Effects of overexpression of PITP family proteins on AbA sensitivity. Wild-type cells harboring pRS425-SEC14, pRS425-SFH1, pRS425-CSR1, pRS425-PDR16, pRS425-PDR17, pRS425-SFH5, or the empty plasmid, were cultured overnight in SC medium lacking leucine, and then spotted onto SC plates lacking leucine with or without the indicated concentrations of AbA, in 10-fold serial dilutions starting with a density of 0.7 A600 units ml −1 . All plates were incubated at 30
• C and photographed after 2 days. overexpression of PDR16 affects the alteration of complex sphingolipid levels by AbA but not the repression of expression of the AUR1 gene, implying that the resistance to AbA due to the overexpression of PDR16 is caused by reduced effectiveness of AbA against intracellular Aur1 activity.
Loss of function of plasma membrane-localized glycerophospholipid flippase overrides the effect of overexpression of PDR16 or PDR17 on AbA sensitivity
It has been reported that ATP-binding cassette (ABC) transporters Pdr5 and Yor1, and plasma membrane-localized glycerophospholipid flippase complexes Dnf1/Lem3 and Dnf2/Lem3, affect the permeability of AbA at the plasma membrane via unknown mechanisms; that is, pdr5 yor1 cells exhibit AbA resistance whereas deletion of LEM3 causes hypersensitivity to AbA (Khakhina et al. 2015) . In addition, the deletion of LEM3 overrides the AbA resistance of pdr5 yor1 cells (Khakhina et al. 2015) . On the other hand, pdr16 pdr17 cells exhibit increased passive drug uptake and hypersensitivity to pleiotropic drugs probably due to alteration of the composition of membrane glycerophospholipids and sterols (van den Hazel et al. 1999) . To assess how Pdr16 affects the effectiveness of AbA, we next examined the effects of the deletion of LEM3 in PDR16-or PDR17-overexpressing cells. As reported previously, lem3 cells exhibited AbA hypersensitivity (Fig. 5A) . The resistance to AbA caused by TEFp-PDR16 or TEFp-PDR17 was dramatically reduced on the deletion of LEM3 (TEFp-PDR16 and TEFp-PDR17 cells versus TEFp-PDR16 lem3 and units ml −1 ) in fresh YPD medium, incubated for 3 h at 30
• C, and then 0 or 0.1 μg ml −1 AbA was added to the culture. Aliquots of cell suspensions were subjected to cell density measurements (A600) at the indicated times. Data represent means ± SD from one experiment (triplicate) representative of three independent experiments. In some instances, error bars are too small to be visible. (C) Time course of growth of tet-AUR1 cells in the presence or absence of Dox. Cells were cultured overnight in YPD medium, diluted (0.018 A600 units ml −1 ) in fresh YPD medium, incubated for 3 h at 30
• C, and then 0 or 10 μg ml TEFp-PDR17 lem3 cells) (Fig. 5A ). In contrast, the deletion of LEM3 did not enhance the growth defect of Dox-treated tet-AUR1, Dox-treated tet-AUR1 TEFp-PDR16, or Dox-treated tet-AUR1 TEFp-PDR17 cells (Fig. 5B) . Rather, the deletion of LEM3 caused weak resistance at a higher concentration of Dox (10 μg ml −1 ) (Fig. 5B) ; however, the mechanism remains unclear. Thus, it was indicated that breakdown of the asymmetry of glycerophospholipids at the plasma membrane overrides the resistance to AbA due to the overexpression of PDR16 or PDR17, implying that the acquisition of resistance to AbA may be related to the structural properties of plasma membranes.
Effect of the overexpression of PDR16 or PDR17 on sensitivities to various drugs
The finding that the overexpression of PDR16 affects the effectiveness of AbA led us to investigate whether or not the overexpression can affect various drug sensitivities. As shown in Fig. 6 , the overexpression of PDR16 or PDR17 caused by the TEF promoter did not confer resistance to cycloheximide, hygromycin B or G418. Rather, the overexpression of PDR16 caused increased sensitivity to these drugs. Similar results were obtained when cells were transformed with the multicopy vector containing PDR16 or PDR17 (data not shown). It has been reported that the overexpression of PDR16 confers resistance to ergosterol biosynthesis inhibitor miconazole (Saidane et al. 2006) ; however, in our experimental conditions, the overexpression of PDR16 slightly improved the cell growth in the presence of 0.3 μg ml −1 miconazole, and the effect of the overexpression was hardly observed in the presence of 0.5 μg ml −1 miconazole. In addition, it was also found that the overexpression of PDR16 or PDR17 confers resistance to myriocin, an inhibitor of serine palmitoyltransferase, which is involved in the first step of the biosynthesis of sphingolipids (Fig. 6 ). Thus, it was suggested that PDR16-or PDR17-overexpressing cells exhibit resistance to some specific drugs, but not to pleiotropic ones.
DISCUSSION
In the present study, we screened for multicopy suppressor genes that confer resistance to AbA, and identified PDR16 and PDR17 (Fig. 1A) . In contrast, deletion of PDR16 and PDR17 caused hypersensitivity to AbA (Fig. 1D ). When expression of the AUR1 gene was repressed by the Tet promoter, the overexpression of PDR16 or PDR17 did not confer resistance to the impaired biosynthesis of complex sphingolipids (Fig. 4A) . Furthermore, the overexpression of PDR16 suppressed the reductions in complex sphingolipid levels caused by the treatment with AbA (Fig. 4D) ; however, the overexpression had no effect on the complex sphingolipid levels in Dox-treated tet-AUR1 cells (Fig. 4E) . Thus, it was indicated that the overexpression of PDR16 affects the effectiveness of AbA against intracellular Aur1 activity and thereby confers resistance to AbA. It should be noted that the overexpression of PDR16 or PDR17 slightly enhanced the growth defect of Dox-treated tet-AUR1 cells ( Fig. 4A and C) . This may suggest that the overexpression is rather deleterious to cells having a defect in complex sphingolipid biosynthesis. When de novo biosynthesis of sphingolipids is impaired, target of rapamycin complex 2 (TORC2) and the Ypk1/2 signaling cascade play important roles in regulation of the sphingolipid levels; that is, the activation of Ypk1/2 upregulates serine palmitoyltransferase and Cer synthases, and confers resistance to sphingolipid biosynthesis inhibitors (Roelants et al. 2011; Muir et al. 2014) . In the absence of AbA, the overexpression of PDR16 did not affect the levels of total complex sphingolipids, or the composition of IPCs, mannosylinositol Figure 6 . Effects of the overexpression of PDR16 or PDR17 on the sensitivity to various drugs. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentration of cycloheximide, hygromycin B, G418, miconazole or myriocin in 10-fold serial dilutions starting with a density of 0.7 A600 units ml −1 . All plates were incubated at 30
• C and photographed after 2 days.
phosphorylceramides (MIPCs) and mannosyldiinositol phosphorylceramides (M(IP) 2 Cs) (Fig. 4D ). In addition, the reductions of complex sphingolipid levels caused by the repression of AUR1 expression were not affected by the overexpression of PDR16 (Fig. 4E) . Thus, it is suggested that the AbA resistance due to the overexpression of PDR16 is not acquired through the activation of intracellular regulation systems for sphingolipid biosynthesis. Pdr16 affects the sensitivity to azole antifungals, which function as ergosterol biosynthesis inhibitors (van den Hazel et al. 1999; Simova et al. 2013) . For example, azoles are used for the treatment of C. albicans infections, and it was shown that some clinical C. albicans isolates exhibiting azole resistance overexpress PDR16 (Saidane et al. 2006) . In S. cerevisiae, single deletion of PDR16, but not PDR17, causes hypersensitivity to azoles (van den Hazel et al. 1999) . In this study, it was found that the single deletion of PDR16 did not affect the sensitivity to AbA; however, pdr17 and pdr16 pdr17 cells exhibited hypersensitivity to AbA (Fig. 1D) . Thus, it is likely that Pdr16 and Pdr17 have different characteristics as to determination of AbA sensitivity compared with those to azole compounds.
It remains unclear as to the precise molecular mechanism by which the overexpression of PDR16 affects the effectiveness of AbA against intracellular Aur1 activity. It was found that the deletion of LEM3, which causes abnormal asymmetry of glycerophospholipids at plasma membranes, overrides the effect of the overexpression of PDR16 or PDR17 on the AbA sensitivity (Fig. 5A) , suggesting that alterations of some structural properties of plasma membranes are important for the acquirement of resistance to AbA due to the overexpression of PDR16 or PDR17.
Thus, the most likely explanation is that PDR16 and PDR17 are involved in the regulation of incorporation of AbA at plasma membranes. It should be noted that AbA resistance in pdr5 yor1 cells is also overriden by the deletion of LEM3 (Khakhina et al. 2015) . The deletion of PDR5 and YOR1 upregulates the expression of genes under the control of the Pdr1 transcriptional factor, which is one of the causes of resistance to AbA in pdr5 yor1 cells. Notably, PDR16 is included in these upregulated genes (Khakhina et al. 2015) . Thus, it is possible that the acquisition of AbA resistance in pdr5 yor1 cells is partly mediated by an increase in the expression level of PDR16. On the contrary, another possible explanation as to why the overexpression of PDR16 or PDR17 confers AbA resistance is that the overexpressing proteins directly bind AbA and reduce the accessibility of the compound to Aur1.
In summary, the present study indicated that PDR16 and PDR17 are involved in the determination of the AbA sensitivity of S. cerevisiae. Further detailed investigation of the effects of Pdr16 and Pdr17 on the action of AbA will provide new insights into the modulation of sensitivity to antifungal drugs in yeast.
